Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Myasthenia Gravis Disease Market Size Growth Rate by Type (2014-2025) 1.4.2 Imaging 1.4.3 Blood Tests 1.4.4 Electrodiagnostic 1.4.5 Edrophonium Test 1.4.6 Pulmonary Function Test 1.5 Market by Application 1.5.1 Global Myasthenia Gravis Disease Market Share by Application (2014-2025) 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Academic Research Institutes 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Myasthenia Gravis Disease Market Size 2.2 Myasthenia Gravis Disease Growth Trends by Regions 2.2.1 Myasthenia Gravis Disease Market Size by Regions (2014-2025) 2.2.2 Myasthenia Gravis Disease Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Myasthenia Gravis Disease Market Size by Manufacturers 3.1.1 Global Myasthenia Gravis Disease Revenue by Manufacturers (2014-2019) 3.1.2 Global Myasthenia Gravis Disease Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Myasthenia Gravis Disease Market Concentration Ratio (CR5 and HHI) 3.2 Myasthenia Gravis Disease Key Players Head office and Area Served 3.3 Key Players Myasthenia Gravis Disease Product/Solution/Service 3.4 Date of Enter into Myasthenia Gravis Disease Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Myasthenia Gravis Disease Market Size by Type (2014-2019) 4.2 Global Myasthenia Gravis Disease Market Size by Application (2014-2019) 5 United States 5.1 United States Myasthenia Gravis Disease Market Size (2014-2019) 5.2 Myasthenia Gravis Disease Key Players in United States 5.3 United States Myasthenia Gravis Disease Market Size by Type 5.4 United States Myasthenia Gravis Disease Market Size by Application 6 Europe 6.1 Europe Myasthenia Gravis Disease Market Size (2014-2019) 6.2 Myasthenia Gravis Disease Key Players in Europe 6.3 Europe Myasthenia Gravis Disease Market Size by Type 6.4 Europe Myasthenia Gravis Disease Market Size by Application 7 China 7.1 China Myasthenia Gravis Disease Market Size (2014-2019) 7.2 Myasthenia Gravis Disease Key Players in China 7.3 China Myasthenia Gravis Disease Market Size by Type 7.4 China Myasthenia Gravis Disease Market Size by Application 8 Japan 8.1 Japan Myasthenia Gravis Disease Market Size (2014-2019) 8.2 Myasthenia Gravis Disease Key Players in Japan 8.3 Japan Myasthenia Gravis Disease Market Size by Type 8.4 Japan Myasthenia Gravis Disease Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Myasthenia Gravis Disease Market Size (2014-2019) 9.2 Myasthenia Gravis Disease Key Players in Southeast Asia 9.3 Southeast Asia Myasthenia Gravis Disease Market Size by Type 9.4 Southeast Asia Myasthenia Gravis Disease Market Size by Application 10 India 10.1 India Myasthenia Gravis Disease Market Size (2014-2019) 10.2 Myasthenia Gravis Disease Key Players in India 10.3 India Myasthenia Gravis Disease Market Size by Type 10.4 India Myasthenia Gravis Disease Market Size by Application 11 Central & South America 11.1 Central & South America Myasthenia Gravis Disease Market Size (2014-2019) 11.2 Myasthenia Gravis Disease Key Players in Central & South America 11.3 Central & South America Myasthenia Gravis Disease Market Size by Type 11.4 Central & South America Myasthenia Gravis Disease Market Size by Application 12 International Players Profiles 12.1 Valeant Pharmaceuticals 12.1.1 Valeant Pharmaceuticals Company Details 12.1.2 Company Description and Business Overview 12.1.3 Myasthenia Gravis Disease Introduction 12.1.4 Valeant Pharmaceuticals Revenue in Myasthenia Gravis Disease Business (2014-2019) 12.1.5 Valeant Pharmaceuticals Recent Development 12.2 Sun Pharmaceuticals Industries 12.2.1 Sun Pharmaceuticals Industries Company Details 12.2.2 Company Description and Business Overview 12.2.3 Myasthenia Gravis Disease Introduction 12.2.4 Sun Pharmaceuticals Industries Revenue in Myasthenia Gravis Disease Business (2014-2019) 12.2.5 Sun Pharmaceuticals Industries Recent Development 12.3 Novartis Pharmaceuticals 12.3.1 Novartis Pharmaceuticals Company Details 12.3.2 Company Description and Business Overview 12.3.3 Myasthenia Gravis Disease Introduction 12.3.4 Novartis Pharmaceuticals Revenue in Myasthenia Gravis Disease Business (2014-2019) 12.3.5 Novartis Pharmaceuticals Recent Development 12.4 Teva Pharmaceutical Industries 12.4.1 Teva Pharmaceutical Industries Company Details 12.4.2 Company Description and Business Overview 12.4.3 Myasthenia Gravis Disease Introduction 12.4.4 Teva Pharmaceutical Industries Revenue in Myasthenia Gravis Disease Business (2014-2019) 12.4.5 Teva Pharmaceutical Industries Recent Development 12.5 Cipla 12.5.1 Cipla Company Details 12.5.2 Company Description and Business Overview 12.5.3 Myasthenia Gravis Disease Introduction 12.5.4 Cipla Revenue in Myasthenia Gravis Disease Business (2014-2019) 12.5.5 Cipla Recent Development 12.6 Roche 12.6.1 Roche Company Details 12.6.2 Company Description and Business Overview 12.6.3 Myasthenia Gravis Disease Introduction 12.6.4 Roche Revenue in Myasthenia Gravis Disease Business (2014-2019) 12.6.5 Roche Recent Development 12.7 Apotex Corporation 12.7.1 Apotex Corporation Company Details 12.7.2 Company Description and Business Overview 12.7.3 Myasthenia Gravis Disease Introduction 12.7.4 Apotex Corporation Revenue in Myasthenia Gravis Disease Business (2014-2019) 12.7.5 Apotex Corporation Recent Development 12.8 Pfizer 12.8.1 Pfizer Company Details 12.8.2 Company Description and Business Overview 12.8.3 Myasthenia Gravis Disease Introduction 12.8.4 Pfizer Revenue in Myasthenia Gravis Disease Business (2014-2019) 12.8.5 Pfizer Recent Development 12.9 Bristol-Myers And Company 12.9.1 Bristol-Myers And Company Company Details 12.9.2 Company Description and Business Overview 12.9.3 Myasthenia Gravis Disease Introduction 12.9.4 Bristol-Myers And Company Revenue in Myasthenia Gravis Disease Business (2014-2019) 12.9.5 Bristol-Myers And Company Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Myasthenia Gravis Disease Key Market Segments Table Key Players Myasthenia Gravis Disease Covered Table Global Myasthenia Gravis Disease Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Myasthenia Gravis Disease Market Size Market Share by Type 2014-2025 Figure Imaging Figures Table Key Players of Imaging Figure Blood Tests Figures Table Key Players of Blood Tests Figure Electrodiagnostic Figures Table Key Players of Electrodiagnostic Figure Edrophonium Test Figures Table Key Players of Edrophonium Test Figure Pulmonary Function Test Figures Table Key Players of Pulmonary Function Test Table Global Myasthenia Gravis Disease Market Size Growth by Application 2014-2025 (Million US$) Figure Hospitals Case Studies Figure Clinics Case Studies Figure Academic Research Institutes Case Studies Figure Myasthenia Gravis Disease Report Years Considered Table Global Myasthenia Gravis Disease Market Size 2014-2025 (Million US$) Figure Global Myasthenia Gravis Disease Market Size and Growth Rate 2014-2025 (Million US$) Table Global Myasthenia Gravis Disease Market Size by Regions 2014-2025 (Million US$) Table Global Myasthenia Gravis Disease Market Size by Regions 2014-2019 (Million US$) Table Global Myasthenia Gravis Disease Market Share by Regions 2014-2019 Figure Global Myasthenia Gravis Disease Market Share by Regions 2014-2019 Figure Global Myasthenia Gravis Disease Market Share by Regions 2019 Table Market Top Trends Table Global Myasthenia Gravis Disease Revenue by Manufacturers (2014-2019) (Million US$) Table Global Myasthenia Gravis Disease Market Share by Manufacturers (2014-2019) Figure Global Myasthenia Gravis Disease Market Share by Manufacturers in 2018 Table Global Myasthenia Gravis Disease Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Myasthenia Gravis Disease Product/Solution/Service Table Date of Enter into Myasthenia Gravis Disease Market Table Mergers & Acquisitions, Expansion Plans Table Global Myasthenia Gravis Disease Market Size by Type (2014-2019) (Million US$) Table Global Myasthenia Gravis Disease Market Size Share by Type (2014-2019) Figure Global Myasthenia Gravis Disease Market Size Market Share by Type (2014-2019) Table Global Myasthenia Gravis Disease Market Size by Application (2014-2019) (Million US$) Table Global Myasthenia Gravis Disease Market Size Share by Application (2014-2019) Figure Global Myasthenia Gravis Disease Market Size Market Share by Application (2014-2019) Figure Global Myasthenia Gravis Disease Revenue Market Share by Application in 2018 Figure United States Myasthenia Gravis Disease Market Size 2014-2019 (Million US$) Table United States Key Players Myasthenia Gravis Disease Revenue (2018-2019) (Million US$) Table United States Key Players Myasthenia Gravis Disease Market Share (2018-2019) Table United States Myasthenia Gravis Disease Market Size by Type (2014-2019) (Million US$) Table United States Myasthenia Gravis Disease Market Share by Type (2014-2019) Table United States Myasthenia Gravis Disease Market Size by Application (2014-2019) (Million US$) Table United States Myasthenia Gravis Disease Market Share by Application (2014-2019) Figure Europe Myasthenia Gravis Disease Market Size 2014-2019 (Million US$) Table Europe Key Players Myasthenia Gravis Disease Revenue (2018-2019) (Million US$) Table Europe Key Players Myasthenia Gravis Disease Market Share (2018-2019) Table Europe Myasthenia Gravis Disease Market Size by Type (2014-2019) (Million US$) Table Europe Myasthenia Gravis Disease Market Share by Type (2014-2019) Table Europe Myasthenia Gravis Disease Market Size by Application (2014-2019) (Million US$) Table Europe Myasthenia Gravis Disease Market Share by Application (2014-2019) Figure China Myasthenia Gravis Disease Market Size 2014-2019 (Million US$) Table China Key Players Myasthenia Gravis Disease Revenue (2018-2019) (Million US$) Table China Key Players Myasthenia Gravis Disease Market Share (2018-2019) Table China Myasthenia Gravis Disease Market Size by Type (2014-20189) (Million US$) Table China Myasthenia Gravis Disease Market Share by Type (2014-2019) Table China Myasthenia Gravis Disease Market Size by Application (2014-2019) (Million US$) Table China Myasthenia Gravis Disease Market Share by Application (2014-2019) Figure Japan Myasthenia Gravis Disease Market Size 2014-2019 (Million US$) Table Japan Key Players Myasthenia Gravis Disease Revenue (2018-2019) (Million US$) Table Japan Key Players Myasthenia Gravis Disease Market Share (2018-2019) Table Japan Myasthenia Gravis Disease Market Size by Type (2014-2019) (Million US$) Table Japan Myasthenia Gravis Disease Market Share by Type (2014-2019) Table Japan Myasthenia Gravis Disease Market Size by Application (2014-2019) (Million US$) Table Japan Myasthenia Gravis Disease Market Share by Application (2014-2019) Figure Southeast Asia Myasthenia Gravis Disease Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Myasthenia Gravis Disease Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Myasthenia Gravis Disease Market Share (2018-2019) Table Southeast Asia Myasthenia Gravis Disease Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Myasthenia Gravis Disease Market Share by Type (2014-2019) Table Southeast Asia Myasthenia Gravis Disease Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Myasthenia Gravis Disease Market Share by Application (2014-2019) Figure India Myasthenia Gravis Disease Market Size 2014-2019 (Million US$) Table India Key Players Myasthenia Gravis Disease Revenue (2018-2019) (Million US$) Table India Key Players Myasthenia Gravis Disease Market Share (2018-2019) Table India Myasthenia Gravis Disease Market Size by Type (2014-2019) (Million US$) Table India Myasthenia Gravis Disease Market Share by Type (2014-2019) Table India Myasthenia Gravis Disease Market Size by Application (2014-2019) (Million US$) Table India Myasthenia Gravis Disease Market Share by Application (2014-2019) Figure Central & South America Myasthenia Gravis Disease Market Size 2014-2019 (Million US$) Table Central & South America Key Players Myasthenia Gravis Disease Revenue (2018-2019) (Million US$) Table Central & South America Key Players Myasthenia Gravis Disease Market Share (2018-2019) Table Central & South America Myasthenia Gravis Disease Market Size by Type (2014-2019) (Million US$) Table Central & South America Myasthenia Gravis Disease Market Share by Type (2014-2019) Table Central & South America Myasthenia Gravis Disease Market Size by Application (2014-2019) (Million US$) Table Central & South America Myasthenia Gravis Disease Market Share by Application (2014-2019) Table Valeant Pharmaceuticals Company Details Table Valeant Pharmaceuticals Revenue in Myasthenia Gravis Disease Business (2014-2019) (Million US$) Figure Valeant Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis Disease Business (2014-2019) Table Valeant Pharmaceuticals Recent Development Table Sun Pharmaceuticals Industries Company Details Table Sun Pharmaceuticals Industries Revenue in Myasthenia Gravis Disease Business (2014-2019)(Million US$) Figure Sun Pharmaceuticals Industries Revenue Growth Rate in Myasthenia Gravis Disease Business (2014-2019) Table Sun Pharmaceuticals Industries Recent Development Table Novartis Pharmaceuticals Company Details Table Novartis Pharmaceuticals Revenue in Myasthenia Gravis Disease Business (2014-2019)(Million US$) Figure Novartis Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis Disease Business (2014-2019) Table Novartis Pharmaceuticals Recent Development Table Teva Pharmaceutical Industries Company Details Table Teva Pharmaceutical Industries Revenue in Myasthenia Gravis Disease Business (2014-2019)(Million US$) Figure Teva Pharmaceutical Industries Revenue Growth Rate in Myasthenia Gravis Disease Business (2014-2019) Table Teva Pharmaceutical Industries Recent Development Table Cipla Company Details Table Cipla Revenue in Myasthenia Gravis Disease Business (2014-2019)(Million US$) Figure Cipla Revenue Growth Rate in Myasthenia Gravis Disease Business (2014-2019) Table Cipla Recent Development Table Roche Company Details Table Roche Revenue in Myasthenia Gravis Disease Business (2014-2019)(Million US$) Figure Roche Revenue Growth Rate in Myasthenia Gravis Disease Business (2014-2019) Table Roche Recent Development Table Apotex Corporation Company Details Table Apotex Corporation Revenue in Myasthenia Gravis Disease Business (2014-2019)(Million US$) Figure Apotex Corporation Revenue Growth Rate in Myasthenia Gravis Disease Business (2014-2019) Table Apotex Corporation Recent Development Table Pfizer Company Details Table Pfizer Revenue in Myasthenia Gravis Disease Business (2014-2019)(Million US$) Figure Pfizer Revenue Growth Rate in Myasthenia Gravis Disease Business (2014-2019) Table Pfizer Recent Development Table Bristol-Myers And Company Company Details Table Bristol-Myers And Company Revenue in Myasthenia Gravis Disease Business (2014-2019)(Million US$) Figure Bristol-Myers And Company Revenue Growth Rate in Myasthenia Gravis Disease Business (2014-2019) Table Bristol-Myers And Company Recent Development Table Global Myasthenia Gravis Disease Market Size by Regions (Million US$) 2019-2025 Figure Global Myasthenia Gravis Disease Market Size Share by Regions (2019-2025) Figure Global Myasthenia Gravis Disease Market Size Share by Regions in 2025 Figure United States Myasthenia Gravis Disease Market Size Forecast (2019-2025)(Million USD) Figure Europe Myasthenia Gravis Disease Market Size Forecast (2019-2025)(Million USD) Figure China Myasthenia Gravis Disease Market Size Forecast (2019-2025)(Million USD) Figure Japan Myasthenia Gravis Disease Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Myasthenia Gravis Disease Market Size Forecast (2019-2025)(Million USD) Figure India Myasthenia Gravis Disease Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Myasthenia Gravis Disease Market Size Forecast (2019-2025)(Million USD) Table Global Myasthenia Gravis Disease Market Size by Product (2019-2025) (Million US$) Figure Global Myasthenia Gravis Disease Market Size by Product (2019-2025) Figure Global Myasthenia Gravis Disease Market Size by Product in 2025 Table Global Myasthenia Gravis Disease Market Size by Application (2019-2025) (Million US$) Figure Global Myasthenia Gravis Disease Market Size by Application (2019-2025) Figure Global Myasthenia Gravis Disease Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Valeant Pharmaceuticals Sun Pharmaceuticals Industries Novartis Pharmaceuticals Teva Pharmaceutical Industries Cipla Roche Apotex Corporation Pfizer Bristol-Myers And Company